Insights for CFOs betting on Intellectual Property

Insights for CFOs betting on Intellectual Property

RELEASE DATE
29-Sep-2015
REGION
Global
Research Code: D61E-01-00-00-00
SKU: LS00084-GL-MR_16925
$4,950.00
In stock
SKU
LS00084-GL-MR_16925
$4,950.00
Links

Pay by invoice

ENQUIRE NOW

Description

Intellectual Property (IP) as a transactional asset has garnered importance in the recent past. This market insight highlights the activities of IP market participants, the business models that they follow and the financial aspects that are related to them.

Table of Contents

Insights for CFOs betting on IP

  • Analysis of Intellectual Property (IP)
Related Research

2016-17 Outlook for Indian Agriculture and Rural Demand

Release Date: 18-May-16
Region: Global

Monthly CPI & WPI Inflation, April 2016

Release Date: 18-May-16
Region: Global

India Investment Tracker January–March 2016

Release Date: 18-May-16
Region: South Asia, Middle East & North Africa

Country Profile – Russia

Release Date: 13-May-16
Region: Asia Pacific

North American Protein Ingredients Market, Forecast to 2020

Release Date: 13-May-16
Region: North America

Global Economic Tracker—Insights and Trends (GET-IT)—Emerging Middle East and Africa Q2 2016

Release Date: 12-May-16
Region: South Asia, Middle East & North Africa

Middle East and North Africa Investment Tracker January-March 2016

Release Date: 11-May-16
Region: South Asia, Middle East & North Africa

Asia-Pacific Telehealth Market Outlook, Forecast to 2020

Release Date: 11-May-16
Region: Asia Pacific

Digital Transformation in the Global Food & Agriculture Market

Release Date: 9-May-2016
Region: North America
Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and greater convenience to patients. This research service evaluates the global market for the pharmaceutical management of type 2 diabetes from 2009 to 2017, with 2012 as the base year. Segmentation by drug type (insulin and non-insulin therapeutics) and regional breakdown are provided. Included are products available in the market, products in development, and patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed.
More Information
No Index No
Podcast No
Author Sudeep Basu
WIP Number D61E-01-00-00-00
Is Prebook No